Amanda Kirane, MD
Surgery · Palo Alto, CANPI 1467656249
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,395 of the $10,961 with a category attached, or 76.6%. Iovance Biotherapeutics, Inc. accounts for 98.6% of it on its own, with 2 other manufacturers making up the rest.
Across 20 payments — averaging $548.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Iovance Biotherapeutics, Inc.$11K
- Intuitive Surgical$104
- Johnson & Johnson$45
Across 4 payments — averaging $69,084 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$276K
What the payments were for
- Speaking & faculty fees$8,39577%
- Travel & lodging$2,12019%
- Food & beverage$4464%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Iovance Biotherapeutics, Inc. | 18 | $10,812 |
| Intuitive Surgical | 1 | $104 |
| Johnson & Johnson | 1 | $45 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Amtagvi$10,475
- Da Vinci Surgical System$104
How this compares
$10,961 in reported general payments places this provider in the 75th percentile of 2,363 surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 23 | $146 |
Paid to pharmacies, not to this prescriber.
Other surgery in Palo Alto
- Beemen KhalilPalo Alto$1.1M
- Micaela EsquivelPalo Alto$158K
- Timothy ChuterSan Francisco$8.8M
- Santiago HorganSan Diego$2.8M
- Rock LiuHayward$1.6M
- David LouriePasadena$1.4M
- Andrea PakulaThousand Oaks$1.4M
- Siew-Ming LeeFresno$1.3M
- John LiphamLos Angeles$942K
- Alexander NedopilLodi$682K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.